Abstract 76: Implications Of Instituting An Eras Pathway In Patients Receiving Chemotherapy In Microsurgical Breast Reconstruction

Documenti analoghi

• Abstract QS22: Defining Enhanced Recovery Pathway With Or Without Liposomal Bupivacaine In Diep Flap Breast Reconstruction
  di: Garza, Ricardo, et al.
  Pubblicazione: (2020)
• Abstract QS14: Abdominal Weakness, Bulge Or Hernia After DIEP Flaps: An Algorithm Of Management, Prevention, And Surgical Repair With Classification
  di: Warren, Abby, et al.
  Pubblicazione: (2020)
• Abstract 67: Patient Selection For DIEP Flap Breast Reconstruction In The Obese Population: Stratifying Surgical Risk Factors For Patient Inclusion Or Exclusion
  di: Jayaraman, Avinash P., et al.
  Pubblicazione: (2020)
• Abstract QS24: Outcomes in Patients Receiving Neoadjuvant Chemotherapy Undergoing Immediate Breast Reconstruction: Effect of Timing and Postoperative Complications
  di: Venutolo, Christopher J., et al.
  Pubblicazione: (2018)
• Abstract QS22: Defining Enhanced Recovery Pathway With Or Without Liposomal Bupivacaine In Diep Flap Breast Reconstruction
  di: Ricardo Garza, Jr., B.S., et al.
  Pubblicazione: (2020-04-01)